Form 4 Tracker
Axsome Therapeutics, Inc.
AXSM

35 insider filings · Latest: Sep 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 16, 2025Sep 16 8:47 PMHerriot Tabuteau
Proposed Sale
19,719$114.10$2.2M—

View →

Sep 15, 2025Sep 15 10:35 PMHerriot Tabuteau
Proposed Sale
15,254$116.78$1.8M—

View →

Sep 12, 2025Sep 12 11:19 PMHerriot Tabuteau
Proposed Sale
27,907$118.42$3.3M—

View →

Sep 5, 2025Sep 5 9:08 PMSaad Mark E
Proposed Sale
9,127$125.07$1.1M—

View →

Sep 2, 2025Sep 2 8:01 PMJEFFS ROGER
Proposed Sale
13,464$123.68$1.7M—

View →

Aug 29, 2025Aug 29 8:02 PMJEFFS ROGER
Proposed Sale
20,000$121.27$2.4M—

View →

Aug 28, 2025Aug 28 8:04 PMJEFFS ROGER
Proposed Sale
20,000$121.60$2.4M—

View →

Aug 27, 2025Aug 27 8:12 PMJEFFS ROGER
Proposed Sale
20,000$122.30$2.4M—

View →

Aug 26, 2025Aug 26 8:08 PMJEFFS ROGER
Proposed Sale
20,000$120.03$2.4M—

View →

Aug 22, 2025Aug 22 8:28 PMJEFFS ROGER
Proposed Sale
16,694$120.08$2.0M—

View →

Jun 23, 2025Jun 23 8:01 PMMurdock Hunter R.
Proposed Sale
6,014$100.12$602.1K—

View →

Jun 20, 2025Jun 20 8:08 PMMurdock Hunter R.
Proposed Sale
7,500$102.47$768.5K—

View →

Jun 18, 2025Jun 18 8:42 PMMurdock Hunter R.
Proposed Sale
7,500$100.90$756.7K—

View →

Jun 17, 2025Jun 17 8:01 PMMurdock Hunter R.
Proposed Sale
7,500$100.26$752.0K—

View →

Jun 16, 2025Jun 16 8:17 PMMurdock Hunter R.
Proposed Sale
7,500$102.42$768.2K—

View →

Jun 9, 2025Jun 9 8:07 PMJacobson Mark L.
Proposed Sale
25,000$110.44$2.8M—

View →

May 28, 2025May 28 9:04 PMColeman Mark
Proposed Sale
3,750$103.43$387.9K—

View →

May 28, 2025May 28 9:03 PMJacobson Mark L.
Proposed Sale
20,000$103.45$2.1M—

View →

May 27, 2025May 27 8:46 PMJacobson Mark L.
Proposed Sale
20,673$0.00$1—

View →

May 27, 2025May 27 8:45 PMColeman Mark
Proposed Sale
3,750$105.47$395.5K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 3, 2026Sep 3 11:09 PMMark L. JacobsonChief Operating Officer
Option Exercise
10,000$12.95104,954(D)

View →

Aug 6, 2026Aug 7 11:00 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
4,660$213.950(D)

View →

Aug 5, 2026Aug 7 11:00 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
45,004$212.014,660(D)

View →

Jul 1, 2026Jul 1 11:30 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
49,666$240.2549,664(D)

View →

Jun 8, 2026Jun 11 1:49 AMRoger JeffsDirector
Option Exercise
1,429—0(D)

View →

Jun 8, 2026Jun 11 1:49 AMMark E SaadDirector
Option Exercise
1,429—0(D)

View →

Jun 8, 2026Jun 11 1:49 AMSusan MahonyDirector
Option Exercise
1,429—0(D)

View →

Jun 8, 2026Jun 11 1:49 AMMark ColemanDirector
Option Exercise
1,429—0(D)

View →

Jun 5, 2026Jun 9 9:18 PMMark ColemanDirector
Grant/Award
1,721—1,721(D)

View →

Jun 5, 2026Jun 9 9:18 PMSusan MahonyDirector
Grant/Award
1,721—1,721(D)

View →

Jun 9, 2026Jun 9 9:17 PMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Option Exercise
49,670$241.0199,330(D)

View →

Jun 9, 2026Jun 9 9:17 PMNick PizzieChief Financial Officer
Option Exercise
33,000$3.5072,000(D)

View →

Jun 5, 2026Jun 9 9:16 PMMark E SaadDirector
Grant/Award
1,721—1,721(D)

View →

Jun 5, 2026Jun 9 9:15 PMRoger JeffsDirector
Grant/Award
1,721—1,721(D)

View →

May 5, 2026May 6 12:34 AMMark L. JacobsonChief Operating Officer
Option Exercise
233$12.95114,954(D)

View →

May 4, 2026May 6 12:34 AMMark L. JacobsonChief Operating Officer
Option Exercise
4,517$12.95115,187(D)

View →

Apr 21, 2026Apr 24 1:02 AMMark L. JacobsonChief Operating Officer
Grant/Award
8,669—8,669(D)

View →

Apr 21, 2026Apr 24 1:02 AMTABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner
Grant/Award
24,081—24,081(D)

View →

Apr 22, 2026Apr 24 1:01 AMAri MaizelChief Commercial Officer
Option Exercise
7,500$70.7323,710(D)

View →

Apr 21, 2026Apr 24 1:01 AMAri MaizelChief Commercial Officer
Grant/Award
7,224—7,224(D)

View →

Page 1 of 2

Next →